Weekly Roundup: UnitedHealth Drops, Eli Lilly Surges, Netflix Rises

On this episode of Stock Movers:

- UnitedHealth Group (UNH) shares fell the most in 26 years. The company cut its annual forecast and reported its first earnings miss in more than a decade, in a foreboding sign that weighed on other insurance stocks. UnitedHealth Group said it was blindsided by rising medical costs as the first quarter closed, upending a forecast it had affirmed just three months ago.

- Eli Lilly (LLY) shares surged after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what’s already one of the fastest growing markets in medicine. The triumph of Ozempic, the blockbuster diabetes shot from Novo Nordisk A/S, and related drugs including Zepbound and Mounjaro from Lilly, has set off an all-out push to develop a pill that’s easier to take and less expensive to make. While rivals including Pfizer have suffered setbacks, analysts said success is critical to creating the $130 billion market they predict by the end of the decade.

- Netflix Inc. reported first-quarter profit that exceeded Wall Street forecasts, boosted by a recent price increase and a strong slate of programming across the globe, like the hit UK series Adolescence. The owner of the world’s most popular online TV network said in a statement Thursday that earnings rose 25% to $6.61 a share, easily beating analysts’ estimates of $5.68. Sales grew 13% to $10.5 billion, in line with projections. This is the first time Netflix has reported financial results without disclosing how many customers it added or lost — the main yardstick investors previously used to gauge the company’s performance. Management is forcing investors to judge its success or failure based on more traditional financial metrics.

See omnystudio.com/listener for privacy information.